Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PHR | HQY |
|---|---|---|
| Price | $10.50 | $91.90 |
| Change today | ▲ 2.44% | ▲ 0.93% |
| Market cap | $651.74M | $7.60B |
| Return, 3 months | -3.0% | -3.1% |
| Return, year to date | -37.9% | +0.3% |
| Return, 1 year | -54.8% | -0.2% |
| P/E (TTM) | 58.3 | 33.2 |
| P/B | 1.8 | 3.8 |
| P/E percentile vs own 5y | 92nd | 38th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +10.4% | +7.6% |
| Net profit growth (YoY) | +193.3% | +9.7% |
| Gross margin | 67.5% | 71.2% |
| Operating margin | 2.5% | 26.1% |
| Net margin | 2.1% | 17.4% |
| Return on equity | 3.1% | 11.4% |
| Analyst target vs. price | +39.7% | +29.4% |
| Analyst buy share | 75% | 100% |
| RSI (14) | 51 | 46 |
| 30-day volatility | 40.6% | 40.0% |
| Max drawdown, 1 year | -66.2% | -30.6% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
